Today's Rundown Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm Abiomed gets Impella pump EUA for coronavirus-related heart failure Hillhouse leads $160M round for Chinese antibody maker Genor Featured Story | | | Tuesday, June 2, 2020 In a pandemic world, the biotech funding environment couldn’t look brighter, and today Pfizer shone its own light. |
|
|---|
|
Top Stories Tuesday, June 2, 2020 From chief scientific officer of Bristol Myers Squibb (back when it still had a hyphen) to running one of the biggest cancer research organizations in the world is a major career shift and challenge at the best of times. Tuesday, June 2, 2020 Gilead Sciences is tapping long-term Stanford University researcher Mark Genovese, M.D., to lead its nonalcoholic steatohepatitis, fibrosis and arthritis pipeline programs. Tuesday, June 2, 2020 FDA Commissioner Stephen Hahn, M.D., has vowed to permanently adopt COVID-19-driven changes that make reviews and authorizations faster. Hahn made the commitment in a speech that called on the FDA to learn from the crisis to enact lasting policies that accelerate drug development. Monday, June 1, 2020 China-based I-MAB Biopharma is advancing its GM-CSF inhibitor into the second phase of a trial in COVID-19 cytokine release syndrome. The company's scientists believe that because the drug works "upstream" in the pro-inflammatory pathway, it will inhibit several cytokines that cause the dangerous syndrome. Monday, June 1, 2020 The FDA granted an emergency authorization to Abiomed’s Impella RP heart pump system for COVID-19 patients suffering from right-sided heart failure, including those with a pulmonary embolism. Tuesday, June 2, 2020 China’s Genor Biopharma banked $160 million from the likes of Hillhouse Capital and Temasek Holdings to advance its clinical-stage autoimmune and cancer programs, prepare the launch of its most advanced prospects and support early-stage R&D. The funds will also support potential partnerships at home and abroad. | | LabConnect is now offering global analytical and operational services to meet your COVID-19 testing requirements. We offer viral load testing by RT-qPCR and multiple COVID-19 screening assays. Connect with LabConnect today. We are here to help. |
Enrollment Showcase | | | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
|
|---|
|
Resources Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Covid-19 has forever changed the paradigm of “go to the office” business operations. Learn how an effective Cloud Strategy can position your company for success in these unprecedented times. Sponsored by: Cenduit, LLC Download this case study to read about how Cenduit navigated these challenges, and successfully supports the trial sponsor to execute the umbrella trial with agility. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 BIO 2020 Now Fully Virtual: Announcing BIO Digital June 8-11, 2020 | Virtual Event Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 